Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
about
Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production.Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.
P2860
Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@ast
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@en
type
label
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@ast
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@en
prefLabel
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@ast
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@en
P2860
P1476
Human immunodeficiency virus t ...... ors: a new therapeutic target.
@en
P2093
P2860
P356
10.1177/095632029901000201
P577
1999-03-01T00:00:00Z